DOI: 10.1128/AAC.00341-20
Article Information
PubMed
Published By
History
- Received February 21, 2020
- Returned for modification April 30, 2020
- Accepted May 25, 2020
- Published online July 22, 2020.
Copyright & Usage
Copyright © 2020 Cheng et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (June 01, 2020).
- You are viewing the most recent version of this article.
Author Information
- aState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, China
- bParasitology Research Laboratory, School of Life Sciences, Xiamen University, Xiamen, Fujian, China
- cMedical College, Xiamen University, Xiamen, Fujian, China
- Address correspondence to Yanhai Wang, wangyh{at}xmu.edu.cn.
Citation Cheng Z, Xu Z, Tian H, Liu F, Li X, Luo D, Wang Y. 2020. In vitro and in vivo efficacies of the EGFR/MEK/ERK signaling inhibitors in the treatment of alveolar echinococcosis. Antimicrob Agents Chemother 64:e00341-20. https://doi.org/10.1128/AAC.00341-20.
